Differential Expression Analysis
P / FL12_F Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
Gene | Annotation | pval | Fold Change (log2ratio) |
---|---|---|---|
cxcl2 | chemokine (C-X-C motif) ligand 2 | 4.090e-6 | 8.311e+0 |
cd83 | CD83 antigen | 4.414e-6 | 6.764e+0 |
lgals3 | lectin, galactose binding, soluble 3 | 9.088e-5 | 6.634e+0 |
lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 1.353e-6 | 6.316e+0 |
cxcl3 | chemokine (C-X-C motif) ligand 3 | 8.314e-4 | 6.174e+0 |
il1b | interleukin 1 beta | 4.708e-4 | 6.147e+0 |
bhlhb2 | basic helix-loop-helix domain containing, class B2 | 1.210e-7 | 6.009e+0 |
pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 9.453e-8 | 5.938e+0 |
spp1 | secreted phosphoprotein 1 | 1.067e-3 | 5.850e+0 |
cxcl10 | chemokine (C-X-C motif) ligand 10 | 5.305e-6 | 5.835e+0 |
olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 4.211e-5 | 5.781e+0 |
s100a9 | S100 calcium binding protein A9 (calgranulin B) | 1.264e-3 | 5.652e+0 |
chi3l3 | chitinase 3-like 3 | 2.711e-3 | 5.633e+0 |
irg1 | immunoresponsive gene 1 | 1.191e-4 | 5.622e+0 |
slfn4 | schlafen 4 | 1.624e-3 | 5.542e+0 |
ccl3 | chemokine (C-C motif) ligand 3 | 4.895e-4 | 5.468e+0 |
ctss | cathepsin S | 8.399e-4 | 5.447e+0 |
s100a8 | S100 calcium binding protein A8 (calgranulin A) | 1.822e-3 | 5.421e+0 |
cd14 | CD14 antigen | 2.038e-3 | 5.363e+0 |
bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 1.695e-4 | 5.347e+0 |
atf3 | activating transcription factor 3 | 1.900e-4 | 5.206e+0 |
cxcl1 | chemokine (C-X-C motif) ligand 1 | 3.145e-3 | 4.973e+0 |
ptgs2 | prostaglandin-endoperoxide synthase 2 | 1.605e-3 | 4.967e+0 |
cpa3 | carboxypeptidase A3, mast cell | 5.597e-7 | 4.933e+0 |
mpeg1 | macrophage expressed gene 1 | 2.042e-3 | 4.882e+0 |
h2-q7 | histocompatibility 2, Q region locus 7 | 6.017e-4 | 4.854e+0 |
il6 | interleukin 6 | 2.725e-3 | 4.854e+0 |
ai607873 | expressed sequence AI607873 | 5.352e-3 | 4.843e+0 |
perp | PERP, TP53 apoptosis effector | 1.469e-6 | 4.825e+0 |
gzmb | granzyme B | 1.341e-6 | 4.800e+0 |
hspa1a | heat shock protein 1A | 3.013e-3 | 4.775e+0 |
nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 2.407e-6 | 4.712e+0 |
emilin2 | elastin microfibril interfacer 2 | 6.530e-7 | 4.685e+0 |
h2-eb1 | histocompatibility 2, class II antigen E beta | 9.141e-4 | 4.677e+0 |
ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 9.152e-3 | 4.650e+0 |
aa467197 | expressed sequence AA467197 | 5.793e-4 | 4.639e+0 |
phlda1 | pleckstrin homology-like domain, family A, member 1 | 4.002e-7 | 4.627e+0 |
fos | FBJ osteosarcoma oncogene | 7.396e-3 | 4.549e+0 |
egr2 | early growth response 2 | 1.435e-3 | 4.548e+0 |
stfa1 | stefin A1 | 1.366e-3 | 4.461e+0 |
hspa1b | heat shock protein 1B | 1.243e-3 | 4.378e+0 |
c1qb | complement component 1, q subcomponent, beta polypeptide | 2.429e-2 | 4.286e+0 |
rmcs5 | response to metastatic cancers 5 | 1.004e-3 | 4.268e+0 |
fosb | FBJ osteosarcoma oncogene B | 2.414e-3 | 4.261e+0 |
thbs1 | thrombospondin 1 | 4.765e-3 | 4.240e+0 |
socs3 | suppressor of cytokine signaling 3 | 5.652e-4 | 4.213e+0 |
ccl12 | chemokine (C-C motif) ligand 12 | 3.835e-2 | 4.153e+0 |
eg622976 | predicted gene, EG622976 | 2.085e-2 | 4.086e+0 |
ccl2 | chemokine (C-C motif) ligand 2 | 1.658e-2 | 4.076e+0 |
2210403k04rik | RIKEN cDNA 2210403K04 gene | 1.835e-6 | 4.045e+0 |
clec7a | C-type lectin domain family 7, member a | 7.222e-3 | 3.985e+0 |
ear2 | eosinophil-associated, ribonuclease A family, member 2 | 1.566e-2 | 3.983e+0 |
ccrl2 | chemokine (C-C motif) receptor-like 2 | 3.024e-3 | 3.961e+0 |
gzmd | granzyme D | 8.201e-3 | 3.956e+0 |
cd69 | CD69 antigen | 5.356e-5 | 3.954e+0 |
clec4n | C-type lectin domain family 4, member n | 2.123e-2 | 3.940e+0 |
adam8 | a disintegrin and metallopeptidase domain 8 | 1.894e-3 | 3.934e+0 |
ccl7 | chemokine (C-C motif) ligand 7 | 2.944e-2 | 3.918e+0 |
ly6c1 | lymphocyte antigen 6 complex, locus C1 | 1.343e-2 | 3.913e+0 |
klf4 | Kruppel-like factor 4 (gut) | 7.765e-4 | 3.899e+0 |
lpxn | leupaxin | 1.296e-3 | 3.886e+0 |
cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 2.149e-5 | 3.856e+0 |
h2-aa | histocompatibility 2, class II antigen A, alpha | 1.708e-3 | 3.843e+0 |
il1r2 | interleukin 1 receptor, type II | 6.809e-6 | 3.817e+0 |
osm | oncostatin M | 4.343e-3 | 3.790e+0 |
ly86 | lymphocyte antigen 86 | 1.074e-2 | 3.766e+0 |
rgs1 | regulator of G-protein signaling 1 | 9.618e-4 | 3.758e+0 |
il1a | interleukin 1 alpha | 1.032e-2 | 3.750e+0 |
il10 | interleukin 10 | 1.964e-2 | 3.746e+0 |
il1rn | interleukin 1 receptor antagonist | 3.119e-2 | 3.743e+0 |
slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 9.800e-3 | 3.741e+0 |
cybb | cytochrome b-245, beta polypeptide | 3.520e-3 | 3.740e+0 |
ccl5 | chemokine (C-C motif) ligand 5 | 5.504e-3 | 3.728e+0 |
areg | amphiregulin | 7.654e-3 | 3.726e+0 |
ifi204 | interferon activated gene 204 | 3.438e-2 | 3.724e+0 |
cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 5.127e-3 | 3.722e+0 |
nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 6.866e-6 | 3.712e+0 |
a130040m12rik | RIKEN cDNA A130040M12 gene | 6.758e-7 | 3.702e+0 |
traf1 | Tnf receptor-associated factor 1 | 1.230e-5 | 3.681e+0 |
0610037m15rik | RIKEN cDNA 0610037M15 gene | 4.476e-3 | 3.670e+0 |
ankrd57 | ankyrin repeat domain 57 | 1.891e-3 | 3.657e+0 |
aif1 | allograft inflammatory factor 1 | 2.993e-2 | 3.625e+0 |
gpc4 | glypican 4 | 3.813e-5 | 3.621e+0 |
c5ar1 | complement component 5a receptor 1 | 6.590e-3 | 3.571e+0 |
c3ar1 | complement component 3a receptor 1 | 2.131e-2 | 3.559e+0 |
9830134c10rik | RIKEN cDNA 9830134C10 gene | 4.546e-5 | 3.501e+0 |
pdpn | podoplanin | 2.279e-2 | 3.496e+0 |
2610034m16rik | RIKEN cDNA 2610034M16 gene | 7.575e-5 | 3.435e+0 |
tnf | tumor necrosis factor | 5.718e-3 | 3.429e+0 |
f13a1 | coagulation factor XIII, A1 subunit | 7.721e-4 | 3.428e+0 |
ctsg | cathepsin G | 2.108e-4 | 3.420e+0 |
tubb2b | tubulin, beta 2b | 6.209e-9 | 3.407e+0 |
ccl6 | chemokine (C-C motif) ligand 6 | 1.465e-2 | 3.394e+0 |
cxcr7 | chemokine (C-X-C motif) receptor 7 | 1.072e-3 | 3.385e+0 |
lpl | lipoprotein lipase | 1.139e-2 | 3.360e+0 |
trem1 | triggering receptor expressed on myeloid cells 1 | 8.951e-4 | 3.352e+0 |
5133401h06rik | RIKEN cDNA 5133401H06 gene | 3.421e-3 | 3.324e+0 |
clec4d | C-type lectin domain family 4, member d | 6.507e-4 | 3.282e+0 |
4930431b09rik | RIKEN cDNA 4930431B09 gene | 1.689e-3 | 3.263e+0 |
ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 1.741e-2 | 3.262e+0 |
prdm1 | PR domain containing 1, with ZNF domain | 1.389e-4 | 3.256e+0 |
lgmn | legumain | 1.454e-2 | 3.244e+0 |
gadd45b | growth arrest and DNA-damage-inducible 45 beta | 7.386e-5 | 3.235e+0 |
ccr7 | chemokine (C-C motif) receptor 7 | 1.133e-3 | 3.234e+0 |
ifi27 | interferon, alpha-inducible protein 27 | 2.658e-2 | 3.231e+0 |
nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 4.001e-6 | 3.226e+0 |
cd36 | CD36 antigen | 1.662e-2 | 3.223e+0 |
slc15a3 | solute carrier family 15, member 3 | 8.121e-3 | 3.204e+0 |
hdc | histidine decarboxylase | 7.024e-6 | 3.187e+0 |
ier3 | immediate early response 3 | 4.845e-6 | 3.164e+0 |
rab20 | RAB20, member RAS oncogene family | 1.883e-2 | 3.155e+0 |
ai426953 | expressed sequence AI426953 | 4.160e-4 | 3.136e+0 |
pira6 | paired-Ig-like receptor A6 | 5.522e-4 | 3.124e+0 |
cst7 | cystatin F (leukocystatin) | 1.429e-4 | 3.121e+0 |
1100001h23rik | RIKEN cDNA 1100001H23 gene | 6.702e-3 | 3.102e+0 |
kel | Kell blood group | 1.525e-7 | 3.080e+0 |
c3 | complement component 3 | 9.803e-3 | 3.077e+0 |
hmox1 | heme oxygenase (decycling) 1 | 2.177e-2 | 3.038e+0 |
map3k8 | mitogen-activated protein kinase kinase kinase 8 | 3.152e-4 | 3.020e+0 |
rnf128 | ring finger protein 128 | 4.403e-3 | 2.997e+0 |
trap1a | tumor rejection antigen P1A | 2.372e-2 | 2.986e+0 |
tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 5.208e-4 | 2.970e+0 |
ear3 | eosinophil-associated, ribonuclease A family, member 3 | 3.798e-2 | 2.958e+0 |
skil | SKI-like | 2.863e-6 | 2.955e+0 |
phf11 | PHD finger protein 11 | 3.155e-2 | 2.950e+0 |
car1 | carbonic anhydrase 1 | 2.117e-4 | 2.948e+0 |
il1rl1 | interleukin 1 receptor-like 1 | 4.996e-6 | 2.946e+0 |
fcgr4 | Fc receptor, IgG, low affinity IV | 2.980e-2 | 2.935e+0 |
mylk3 | myosin light chain kinase 3 | 3.998e-5 | 2.929e+0 |
pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 3.083e-2 | 2.918e+0 |
emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 2.293e-2 | 2.915e+0 |
s100a6 | S100 calcium binding protein A6 (calcyclin) | 3.265e-3 | 2.902e+0 |
gata1 | GATA binding protein 1 | 7.443e-7 | 2.900e+0 |
fcgr3 | Fc receptor, IgG, low affinity III | 1.628e-4 | 2.881e+0 |
1190002h23rik | RIKEN cDNA 1190002H23 gene | 2.910e-4 | 2.861e+0 |
zfp36 | zinc finger protein 36 | 2.750e-3 | 2.857e+0 |
mefv | Mediterranean fever | 1.789e-2 | 2.851e+0 |
pdk4 | pyruvate dehydrogenase kinase, isoenzyme 4 | 4.118e-8 | 2.841e+0 |
krt8 | keratin 8 | 2.694e-2 | 2.814e+0 |
plk2 | polo-like kinase 2 (Drosophila) | 6.592e-4 | 2.789e+0 |
4631422o05rik | RIKEN cDNA 4631422O05 gene | 6.904e-5 | 2.788e+0 |
rgs16 | regulator of G-protein signaling 16 | 2.886e-5 | 2.780e+0 |
hck | hemopoietic cell kinase | 8.402e-3 | 2.769e+0 |
ramp3 | receptor (calcitonin) activity modifying protein 3 | 3.427e-5 | 2.752e+0 |
maff | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | 1.010e-3 | 2.743e+0 |
scin | scinderin | 2.108e-8 | 2.725e+0 |
apoc2 | apolipoprotein C-II | 2.372e-2 | 2.717e+0 |
spin4 | spindlin family, member 4 | 1.882e-6 | 2.698e+0 |
tlr13 | toll-like receptor 13 | 1.858e-2 | 2.677e+0 |
nap1l5 | nucleosome assembly protein 1-like 5 | 9.726e-5 | 2.673e+0 |
bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 1.733e-5 | 2.673e+0 |
ifitm6 | interferon induced transmembrane protein 6 | 1.980e-2 | 2.667e+0 |
slpi | secretory leukocyte peptidase inhibitor | 2.512e-2 | 2.665e+0 |
relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 5.233e-5 | 2.663e+0 |
ccr1 | chemokine (C-C motif) receptor 1 | 3.881e-2 | 2.660e+0 |
alox5 | arachidonate 5-lipoxygenase | 6.727e-6 | 2.655e+0 |
ab124611 | cDNA sequence AB124611 | 1.365e-2 | 2.655e+0 |
gzmc | granzyme C | 4.654e-3 | 2.655e+0 |
dse | dermatan sulfate epimerase | 9.379e-3 | 2.654e+0 |
egr1 | early growth response 1 | 4.590e-3 | 2.645e+0 |
klrd1 | killer cell lectin-like receptor, subfamily D, member 1 | 9.543e-5 | 2.643e+0 |
clec1b | C-type lectin domain family 1, member b | 4.044e-3 | 2.637e+0 |
pf4 | platelet factor 4 | 2.894e-2 | 2.635e+0 |
rel | reticuloendotheliosis oncogene | 8.914e-5 | 2.628e+0 |
egr3 | early growth response 3 | 2.630e-8 | 2.623e+0 |
stx11 | syntaxin 11 | 1.947e-4 | 2.608e+0 |
bmp2 | bone morphogenetic protein 2 | 3.046e-5 | 2.598e+0 |
cd300lb | CD300 antigen like family member B | 7.669e-3 | 2.594e+0 |
sgk1 | serum/glucocorticoid regulated kinase 1 | 7.751e-3 | 2.585e+0 |
cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 2.470e-3 | 2.582e+0 |
pparg | peroxisome proliferator activated receptor gamma | 2.003e-2 | 2.581e+0 |
irak2 | interleukin-1 receptor-associated kinase 2 | 3.897e-4 | 2.580e+0 |
fpr2 | formyl peptide receptor 2 | 4.377e-2 | 2.576e+0 |
itgax | integrin alpha X | 1.966e-2 | 2.568e+0 |
pira1 | paired-Ig-like receptor A1 | 1.774e-4 | 2.566e+0 |
siglec5 | sialic acid binding Ig-like lectin 5 | 7.233e-4 | 2.563e+0 |
rasgef1b | RasGEF domain family, member 1B | 2.921e-4 | 2.562e+0 |
ermap | erythroblast membrane-associated protein | 9.471e-4 | 2.559e+0 |
btg1 | B-cell translocation gene 1, anti-proliferative | 1.735e-4 | 2.554e+0 |
nlrp3 | NLR family, pyrin domain containing 3 | 7.203e-3 | 2.550e+0 |
rsad2 | radical S-adenosyl methionine domain containing 2 | 2.596e-2 | 2.549e+0 |
sdc4 | syndecan 4 | 2.560e-2 | 2.544e+0 |
rrad | Ras-related associated with diabetes | 4.549e-7 | 2.543e+0 |
itgb5 | integrin beta 5 | 8.853e-3 | 2.543e+0 |
ccl4 | chemokine (C-C motif) ligand 4 | 1.999e-2 | 2.541e+0 |
dusp1 | dual specificity phosphatase 1 | 8.081e-3 | 2.539e+0 |
ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 | 4.327e-3 | 2.524e+0 |
fcgr2b | Fc receptor, IgG, low affinity IIb | 7.929e-3 | 2.516e+0 |
1200016e24rik | RIKEN cDNA 1200016E24 gene | 3.929e-4 | 2.513e+0 |
rabgef1 | RAB guanine nucleotide exchange factor (GEF) 1 | 1.417e-5 | 2.494e+0 |
4930506m07rik | RIKEN cDNA 4930506M07 gene | 3.398e-2 | 2.484e+0 |
bcl6 | B-cell leukemia/lymphoma 6 | 6.496e-5 | 2.484e+0 |
lincr | lung-inducible neuralized-related C3HC4 RING domain protein | 1.919e-3 | 2.481e+0 |
fgl2 | fibrinogen-like protein 2 | 3.412e-3 | 2.471e+0 |
coq10b | coenzyme Q10 homolog B (S. cerevisiae) | 1.057e-4 | 2.460e+0 |
cpeb2 | cytoplasmic polyadenylation element binding protein 2 | 7.162e-4 | 2.452e+0 |
atp8b4 | ATPase, class I, type 8B, member 4 | 2.312e-3 | 2.445e+0 |
pmp22 | peripheral myelin protein 22 | 3.294e-2 | 2.443e+0 |
havcr2 | hepatitis A virus cellular receptor 2 | 2.016e-2 | 2.431e+0 |
cxcl16 | chemokine (C-X-C motif) ligand 16 | 3.278e-2 | 2.426e+0 |
gpr183 | G protein-coupled receptor 183 | 5.497e-4 | 2.411e+0 |
agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 2.767e-2 | 2.399e+0 |
h2-gs10 | MHC class I like protein GS10 | 3.244e-2 | 2.355e+0 |
clec4e | C-type lectin domain family 4, member e | 1.036e-2 | 2.355e+0 |
tubb3 | tubulin, beta 3 | 9.673e-4 | 2.342e+0 |
f10 | coagulation factor X | 2.795e-2 | 2.336e+0 |
errfi1 | ERBB receptor feedback inhibitor 1 | 1.011e-2 | 2.335e+0 |
nr4a2 | nuclear receptor subfamily 4, group A, member 2 | 3.040e-5 | 2.319e+0 |
kcne3 | potassium voltage-gated channel, Isk-related subfamily, gene 3 | 1.006e-2 | 2.316e+0 |
slc45a3 | solute carrier family 45, member 3 | 1.826e-5 | 2.314e+0 |
h2-q8 | histocompatibility 2, Q region locus 8 | 3.150e-2 | 2.314e+0 |
gpnmb | glycoprotein (transmembrane) nmb | 4.980e-2 | 2.307e+0 |
slc7a8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 4.513e-4 | 2.295e+0 |
1700006j14rik | RIKEN cDNA 1700006J14 gene | 6.438e-4 | 2.294e+0 |
dusp8 | dual specificity phosphatase 8 | 1.330e-5 | 2.293e+0 |
bcl3 | B-cell leukemia/lymphoma 3 | 1.898e-6 | 2.291e+0 |
lmna | lamin A | 7.075e-9 | 2.275e+0 |
glipr1 | GLI pathogenesis-related 1 (glioma) | 3.134e-5 | 2.269e+0 |
ptger4 | prostaglandin E receptor 4 (subtype EP4) | 6.513e-3 | 2.265e+0 |
lin28 | lin-28 homolog (C. elegans) | 3.499e-5 | 2.263e+0 |
nuak2 | NUAK family, SNF1-like kinase, 2 | 3.823e-4 | 2.263e+0 |
nfil3 | nuclear factor, interleukin 3, regulated | 1.131e-3 | 2.260e+0 |
loc100047353 | similar to myocardial vascular inhibition factor | 2.656e-5 | 2.249e+0 |
klf2 | Kruppel-like factor 2 (lung) | 2.545e-2 | 2.248e+0 |
ccrn4l | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 1.431e-4 | 2.240e+0 |
ms4a7 | membrane-spanning 4-domains, subfamily A, member 7 | 2.321e-2 | 2.233e+0 |
hp | haptoglobin | 1.705e-2 | 2.226e+0 |
dab2 | disabled homolog 2 (Drosophila) | 2.317e-2 | 2.224e+0 |
3021401c12rik | RIKEN cDNA 3021401C12 gene | 9.665e-3 | 2.209e+0 |
g0s2 | G0/G1 switch gene 2 | 1.544e-2 | 2.207e+0 |
gda | guanine deaminase | 4.740e-2 | 2.206e+0 |
fcer1g | Fc receptor, IgE, high affinity I, gamma polypeptide | 3.047e-3 | 2.204e+0 |
oaf | OAF homolog (Drosophila) | 1.195e-4 | 2.203e+0 |
cdh17 | cadherin 17 | 9.495e-4 | 2.200e+0 |
plek | pleckstrin | 1.901e-4 | 2.179e+0 |
gp1bb | glycoprotein Ib, beta polypeptide | 3.518e-5 | 2.178e+0 |
apobec2 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 | 4.751e-4 | 2.164e+0 |
adora2b | adenosine A2b receptor | 4.630e-2 | 2.162e+0 |
4732429d16rik | RIKEN cDNA 4732429D16 gene | 3.263e-2 | 2.157e+0 |
steap4 | STEAP family member 4 | 4.862e-4 | 2.153e+0 |
tubb1 | tubulin, beta 1 | 4.798e-2 | 2.148e+0 |
s100a4 | S100 calcium binding protein A4 | 4.840e-2 | 2.134e+0 |
2010002n04rik | RIKEN cDNA 2010002N04 gene | 3.872e-4 | 2.128e+0 |
rhob | ras homolog gene family, member B | 1.811e-3 | 2.128e+0 |
rnf19b | ring finger protein 19B | 1.878e-3 | 2.117e+0 |
gna14 | guanine nucleotide binding protein, alpha 14 | 9.255e-6 | 2.111e+0 |
mreg | melanoregulin | 1.963e-3 | 2.108e+0 |
nupr1 | nuclear protein 1 | 3.742e-2 | 2.097e+0 |
junb | Jun-B oncogene | 3.321e-4 | 2.097e+0 |
a430093f15rik | RIKEN cDNA A430093F15 gene | 1.375e-4 | 2.080e+0 |
tnfaip2 | tumor necrosis factor, alpha-induced protein 2 | 4.274e-3 | 2.077e+0 |
dtx4 | deltex 4 homolog (Drosophila) | 2.239e-3 | 2.077e+0 |
papss2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 4.706e-4 | 2.076e+0 |
fabp4 | fatty acid binding protein 4, adipocyte | 2.140e-2 | 2.074e+0 |
csf2rb2 | colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) | 6.672e-3 | 2.070e+0 |
lrrc16a | leucine rich repeat containing 16A | 8.552e-3 | 2.068e+0 |
gpr84 | G protein-coupled receptor 84 | 5.995e-4 | 2.065e+0 |
dusp4 | dual specificity phosphatase 4 | 2.931e-4 | 2.061e+0 |
stab1 | stabilin 1 | 1.285e-2 | 2.057e+0 |
klf6 | Kruppel-like factor 6 | 1.053e-2 | 2.049e+0 |
c030046g05 | hypothetical protein C030046G05 | 2.617e-5 | 2.048e+0 |
hapln1 | hyaluronan and proteoglycan link protein 1 | 5.645e-4 | 2.040e+0 |
treml4 | triggering receptor expressed on myeloid cells-like 4 | 3.848e-2 | 2.028e+0 |
bag3 | BCL2-associated athanogene 3 | 3.138e-3 | 2.021e+0 |
hist1h1c | histone cluster 1, H1c | 2.732e-4 | 2.018e+0 |
blnk | B-cell linker | 4.134e-2 | 2.014e+0 |
tlr2 | toll-like receptor 2 | 4.613e-2 | 2.012e+0 |
nkg7 | natural killer cell group 7 sequence | 7.607e-4 | 2.005e+0 |
armcx1 | armadillo repeat containing, X-linked 1 | 1.230e-3 | -2.021e+0 |
mn1 | meningioma 1 | 1.405e-3 | -2.033e+0 |
gimap8 | GTPase, IMAP family member 8 | 7.644e-4 | -2.052e+0 |
hoxa3 | homeo box A3 | 2.684e-5 | -2.054e+0 |
thsd1 | thrombospondin, type I, domain 1 | 3.723e-5 | -2.055e+0 |
zfp467 | zinc finger protein 467 | 1.885e-4 | -2.055e+0 |
gprc5b | G protein-coupled receptor, family C, group 5, member B | 6.790e-5 | -2.059e+0 |
eya2 | eyes absent 2 homolog (Drosophila) | 2.056e-4 | -2.071e+0 |
rbp1 | retinol binding protein 1, cellular | 9.158e-4 | -2.125e+0 |
1110017f19rik | RIKEN cDNA 1110017F19 gene | 2.039e-4 | -2.160e+0 |
rassf9 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 | 3.470e-5 | -2.184e+0 |
zfp94 | zinc finger protein 94 | 5.027e-5 | -2.217e+0 |
ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 4.040e-3 | -2.222e+0 |
2010004m13rik | RIKEN cDNA 2010004M13 gene | 3.408e-5 | -2.223e+0 |
gfi1 | growth factor independent 1 | 9.329e-4 | -2.239e+0 |
a830059i20rik | RIKEN cDNA A830059I20 gene | 3.060e-5 | -2.426e+0 |
hoxa9 | homeo box A9 | 4.826e-5 | -2.449e+0 |
dkk1 | dickkopf homolog 1 (Xenopus laevis) | 3.147e-7 | -2.451e+0 |
ai449310 | expressed sequence AI449310 | 1.709e-3 | -2.532e+0 |
0610040b09rik | RIKEN cDNA 0610040B09 gene | 2.646e-4 | -2.608e+0 |
hlf | hepatic leukemia factor | 3.404e-5 | -2.656e+0 |
zfp760 | zinc finger protein 760 | 6.560e-6 | -2.740e+0 |
sox18 | SRY-box containing gene 18 | 2.244e-3 | -2.788e+0 |